Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Functional dyspepsia.

Jan H Kleibeuker1, Jaap C Thijs

  • 1Department of Gastroenterology and Hepatology, University Hospital, Groningen, The Netherlands. j.h.kleibeuker@int.azg.nl

Current Opinion in Gastroenterology
|February 11, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Back-Table Fluorescence-Guided Imaging for Circumferential Resection Margin Evaluation Using Bevacizumab-800CW in Patients with Locally Advanced Rectal Cancer.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2019
Same author

Quantitative fluorescence endoscopy: an innovative endoscopy approach to evaluate neoadjuvant treatment response in locally advanced rectal cancer.

Gut·2019
Same author

Effect of chromoendoscopy in the proximal colon on colorectal neoplasia detection in Lynch syndrome: a multicenter randomized controlled trial.

Gastrointestinal endoscopy·2019
Same author

Circulating miRNAs in patients with Barrett's esophagus, high-grade dysplasia and esophageal adenocarcinoma.

Journal of gastrointestinal oncology·2019
Same author

Potential Red-Flag Identification of Colorectal Adenomas with Wide-Field Fluorescence Molecular Endoscopy.

Theranostics·2018
Same author

Near-infrared fluorescence molecular endoscopy detects dysplastic oesophageal lesions using topical and systemic tracer of vascular endothelial growth factor A.

Gut·2017
Same journal

Endoscopic techniques to minimize gastroesophageal reflux during peroral endoscopic myotomy.

Current opinion in gastroenterology·2026
Same journal

Postendoscopy esophageal adenocarcinoma and neoplasia: current status and future directions.

Current opinion in gastroenterology·2026
Same journal

The complement system in inflammatory bowel disease: from early observations to emerging frontiers.

Current opinion in gastroenterology·2026
Same journal

Goblet cell-associated antigen passages in health and disease.

Current opinion in gastroenterology·2026
Same journal

Inflammatory bowel diseases 2026: form, function and therapeutic considerations for the epithelial barrier.

Current opinion in gastroenterology·2026
Same journal

Dietary protein as a regulator of colitis and colorectal cancer.

Current opinion in gastroenterology·2026
See all related articles

Functional dyspepsia (FD) therapy is evolving. While Helicobacter pylori causes a minority of cases, new options like hypnotherapy show promise for managing this common, often empirical, condition.

Area of Science:

  • Gastroenterology
  • Internal Medicine
  • Clinical Therapeutics

Background:

  • Functional dyspepsia (FD) is a prevalent gastrointestinal disorder with largely unknown causes and variable pathophysiology.
  • Current therapeutic approaches for FD are predominantly empirical, lacking targeted strategies based on underlying mechanisms.
  • Recent research offers new insights into the etiology and pathophysiologic mechanisms of FD, paving the way for more personalized treatments.

Purpose of the Study:

  • To review recent advancements in understanding the etiology and pathophysiology of functional dyspepsia.
  • To explore emerging therapeutic options for functional dyspepsia beyond traditional empirical treatments.
  • To evaluate the role of specific mechanisms, such as Helicobacter pylori infection, in FD pathogenesis.

Main Methods:

Related Experiment Videos

  • Review of recent scientific literature on functional dyspepsia.
  • Analysis of studies investigating symptom-pathophysiology associations in FD.
  • Evaluation of emerging pharmacotherapeutic and non-pharmacotherapeutic treatment options for FD.

Main Results:

  • Helicobacter pylori gastritis is identified as a causative factor in a small subset of FD patients.
  • Established associations exist between symptom clusters and pathophysiologic mechanisms, though individual relevance remains uncertain due to symptom variability.
  • Limited progress in pharmacotherapy, but hypnotherapy emerges as a promising alternative treatment for functional dyspepsia.

Conclusions:

  • Diagnostic strategies for suspected FD primarily focus on excluding other disorders like peptic ulcer disease and gastroesophageal reflux disease.
  • Acid-suppressive therapy (e.g., proton pump inhibitors) is recommended for FD with reflux symptoms; otherwise, treatment remains empirical.
  • Hypnotherapy presents a viable and potentially effective therapeutic option for managing functional dyspepsia.